The Family Foundation Response to U.S. Supreme Court Abortion Drug Ruling

Today, the U.S. Supreme Court released a unanimous decision holding that the Alliance for Hippocratic Medicine lacked standing to challenge the Food and Drug Administration’s approval of the abortion drug mifepristone. However, the Court did recognize the importance of federal conscience rights for pro-life physicians.

The Family Foundation, along with more than 35 allied pro-life organizations, filed a “friend of the court” amicus brief in the case urging the U.S. Supreme Court to stop the FDA’s unlawful approval of chemical abortion drugs and its disregard for women’s health.

Statement from David Walls, Executive Director of The Family Foundation:

“We are disappointed the Supreme Court did not rule on the merits of the FDA’s unlawful and reckless removal of safety standards for abortion drugs. Because of today’s ruling, the FDA and Biden Administration will continue to put the lives of unborn babies and the health of their mothers at risk, with the FDA’s own label admitting that 1 in 25 women will visit the ER after using the drug.

“But despite this temporary setback, the pro-life movement is committed to continuing to fight for moms and their unborn children, while seeking to hold the FDA accountable for endangering women and girls. Thankfully, Kentucky’s strong pro-life laws that prohibit abortion and restrict the prescribing, distribution, and mailing of abortion drugs remain in full effect,” Walls concluded.

Since 2000, millions of preborn children have lost their lives to the chemical abortion pill. In addition, the chemical abortion drugs that are being pushed and illegally trafficked through mail, without seeing a doctor, have resulted in serious additional safety and health issues for women.


The Family Foundation is the leading Christian public policy organization in Kentucky and stands for Kentucky families and the Biblical values that make them strong. Learn more at

Leave a Reply